[Federal Register Volume 85, Number 142 (Thursday, July 23, 2020)]
[Notices]
[Page 44537]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-15932]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Notice of Meeting

AGENCY: Agency for Healthcare Research and Quality, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Agency for Healthcare Research and Quality (AHRQ) 
announces a Special Emphasis Panel (SEP) meeting on ``AHRQ RFAHS20-002 
Supporting Primary Care to Advance Cardiovascular Health in States with 
High Prevalence of Preventable CVD Events (U18).'' This SEP meeting 
will be closed to the public.

DATES: August 25, 2020.

ADDRESSES: Agency for Healthcare Research and Quality, (Video Assisted 
Review), 5600 Fishers Lane, Rockville, Maryland 20850.

FOR FURTHER INFORMATION CONTACT: Jenny Griffith, Committee Management 
Officer, Office of Extramural Research, Education and Priority 
Populations, Agency for Healthcare Research and Quality, (AHRQ), 5600 
Fishers Lane, Rockville, Maryland 20850, Telephone: (301) 427-1557.

SUPPLEMENTARY INFORMATION: A Special Emphasis Panel is a group of 
experts in fields related to health care research who are invited by 
AHRQ, and agree to be available, to conduct on an as needed basis, 
scientific reviews of applications for AHRQ support. Individual members 
of the Panel do not attend regularly-scheduled meetings and do not 
serve for fixed terms or a long period of time. Rather, they are asked 
to participate in particular review meetings which require their type 
of expertise.
    The SEP meeting referenced above will be closed to the public in 
accordance with the provisions set forth in 5 U.S.C. App. 2, section 
10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). Grant applications 
for the ``AHRQ RFAHS20-002 Supporting Primary Care to Advance 
Cardiovascular Health in States with High Prevalence of Preventable CVD 
Events (U18).'' are to be reviewed and discussed at this meeting. The 
grant applications and the discussions could disclose confidential 
trade secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the grant 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.
    Agenda items for this meeting are subject to change as priorities 
dictate.

    Dated: July 17, 2020.
Virginia L. Mackay-Smith,
Associate Director.
[FR Doc. 2020-15932 Filed 7-22-20; 8:45 am]
BILLING CODE 4160-90-P